Metastatic renal-cell carcinoma: what causes occasional dramatic regressions?

Article Abstract:

More research is needed before immunotherapy with cytokines can be recommended for patients with a type of kidney cancer called renal-cell carcinoma. The primary tumor is often removed surgically but 25% to 30% of patients have metastatic disease at the time of treatment. Some untreated patients have gone into remission, leading physicians to believe that immunotherapy might be beneficial. However, two 1998 studies of interferon and interleukin-2 indicate that these immune system proteins may not benefit patients. Combining interferon and interleukin-2 may be beneficial but also causes serious side effects.

Health aspects, Editorial, Interferon, Interleukin-2, Carcinoma, Renal cell, Renal cell carcinoma

---

Medical progress: the pathogenesis of mycosis fungoides

Article Abstract:

The expanding armamentarium of biologic agents, phototheraputic and irradiation techniques and combination regimens available to treat mycosis fungoides is discussed.

United States, Development and progression, Lymphoproliferative disorders, Mycosis fungoides

---

Similar abstracts:

• Abstracts: Mycosis fungoides: the therapeutic search continues. Chemotherapy of lung cancer. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides
• Abstracts: Birth-day choices. Making motherhood safe in developing countries. Outcomes of care in birth centers

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.